72 related articles for article (PubMed ID: 16840836)
1. Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study.
Debets P; Dreijerink KMA; Engelsman A; Dahele M; Haak HR; Steenaard RV; Kapiteijn E; Corssmit E; Menke-van der Houven van Oordt CW
Eur J Cancer; 2024 Jan; 196():113424. PubMed ID: 37977106
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Rate Brachytherapy Combined with PD-1 Blockade as a Treatment for Metastatic Adrenocortical Carcinoma - A Single Center Case Series.
Schwarzlmueller P; Corradini S; Seidensticker M; Zimmermann P; Schreiner J; Maier T; Triebig A; Knösel T; Pazos M; Pfluger T; Weigand I; Belka C; Ricke J; Reincke M; Schmidmaier R; Kroiss M
Horm Metab Res; 2024 Jan; 56(1):30-37. PubMed ID: 37748508
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma.
Shetty I; Fuller S; Raygada M; Merino MJ; Thomas BJ; Widemann BC; Reilly KM; Pacak K; Del Rivero J
Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31917677
[TBL] [Abstract][Full Text] [Related]
4. Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy.
Yamamoto A; Nakai Y; Oka T; Kanaki T; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Nishimura K
IJU Case Rep; 2020 Nov; 3(6):270-273. PubMed ID: 33163922
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinoma presenting as a rupture and extensive retroperitoneal haemorrhage.
Jagtap SV; Desai S; Halder S; Jagtap SS; Badwe AS
J Clin Diagn Res; 2014 Mar; 8(3):117-8. PubMed ID: 24783099
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience.
Laganà M; Grisanti S; Cosentini D; Ferrari VD; Lazzari B; Ambrosini R; Sardini C; Volta AD; Palumbo C; Poliani PL; Terzolo M; Sigala S; Tiberio GAM; Berruti A
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290298
[TBL] [Abstract][Full Text] [Related]
7. Management of adrenal cancer: a 2013 update.
Terzolo M; Daffara F; Ardito A; Zaggia B; Basile V; Ferrari L; Berruti A
J Endocrinol Invest; 2014 Mar; 37(3):207-17. PubMed ID: 24458831
[TBL] [Abstract][Full Text] [Related]
8. Oncocytic adrenocortical carcinoma.
Tanaka K; Kumano Y; Kanomata N; Takeda M; Hara I; Fujisawa M; Kawabata G; Kamidono S
Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302503
[TBL] [Abstract][Full Text] [Related]
9. Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
Burgess MA
Minerva Endocrinol; 1995 Mar; 20(1):101-4. PubMed ID: 7651278
[No Abstract] [Full Text] [Related]
10. Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.
Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L
J Endocrinol Invest; 2006 Jun; 29(6):560-2. PubMed ID: 16840836
[TBL] [Abstract][Full Text] [Related]
11. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.
Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Sep; 12(3):657-66. PubMed ID: 16172198
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
13. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
14. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
[TBL] [Abstract][Full Text] [Related]
15. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
Hantel C; Jung S; Mussack T; Reincke M; Beuschlein F
Endocr Relat Cancer; 2014 Jun; 21(3):383-94. PubMed ID: 24532475
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
